The US Department of State has announced a life-saving development to bring US-based Gilead Sciences’ breakthrough drug ...
HIV and AIDS healthcare workers are uncertain about what the future holds in light of continuous federal funding cuts to ...
The Institute of Human Virology Nigeria has urged People Living with HIV to adhere to their prescribed medications to ...
A new study led by researchers at the George Washington University and published through the DC Cohort, one of the largest HIV longitudinal studies in the United States, finds that nearly half of ...
South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...
Aaron Motsoaledi warned, however, that initial distribution of the drug would be limited to nearly half a million people.
Health Minister Dr Aaron Motsoaledi announced that the national rollout is expected to begin by March or April 2026, ...
South Africa’s health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a “groundbreaking” tool ...
A new drug called lenacapavir might entirely change the game, though.
Lia Head-Rigby works with Palm Beach County's HIV Services, which is aiming to reduce new HIV infections by 90% by 2030 ...
Lenacapavir is a breakthrough long-acting HIV prevention drug, which Motsoaledi has labelled a turning point in the country’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results